CMS Open Payments · Program Year 2024
MIS Implants Technologies, Inc.
MIS Implants Technologies, Inc. reported $62,874.00 across General Payments, Research, and Ownership to 11 physicians and teaching hospitals across 12 transactions.
- $62.9K Below-median payer
- All-tracks total
- 12 Below-median volume
- Transactions
- 11 Below-median reach
- Recipients
- −$18.0K
- General Payments vs PY2023
MIS Implants Technologies, Inc. reported $62,874.00 across all CMS Open Payments tracks (General + Research + Ownership) to 11 physicians and teaching hospitals in Program Year 2024 - ranking #1291 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $56,381.00, averaging $5.7K per recipient.
How MIS Implants Technologies, Inc.'s $62.9K all-tracks total breaks down
MIS Implants Technologies, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mis-implants-technologies-inc MIS Implants Technologies, Inc.
$62.9K · #1291/1,925 · 0.0% industry · PY2024
- TOT $62.9K
- RANK #1291
- SHARE 0.0%
- TXN 12
- RCP 11
- CAT 2
- GEN $56.4K
- ΔGEN −$18.0K
- TOP1 32.2%
- PY 2024
Volume peers
Nearest volume peer: Dentium USA ($63.0K)
MIS Implants Technologies, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
MIS Implants Technologies, Inc.'s CMS-reported General Payments decreased by $18.0K (−24.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MIS IMPLANTS TECHNOLOGIES, INC.PY2023: MIS IMPLANTS TECHNOLOGIES, INC.PY2024: MIS Implants Technologies, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $74,422.00
- PY2024
- $56,381.00
What the Data Shows for MIS Implants Technologies, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For MIS Implants Technologies, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
7 transactions worth $43.6K make "Compensation for Faculty or Speaker (Medical Education)" the top general-payment category in the 2-category breakdown below, 77.3% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, MIS Implants Technologies, Inc.'s largest category was "Compensation for Faculty or Speaker (Medical Education)" at $43.6K - 77.3% of General Payments.
How MIS Implants Technologies, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Faculty or Speaker (Medical Education) | $43.6K | 7 | 77.3% |
| Travel and Lodging | $12.8K | 4 | 22.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $56,381.00 (100.0%) of $56,381.00 in this company's General Payments records across 5 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for MIS Implants Technologies, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Ariel Raigrodski
$18,178.00 across 4 reported transactions
- 2
Wael Att
$17,106.00 across 2 reported transactions
- 3
Tara Lyn Aghaloo
$12,247.00 across 3 reported transactions
- 4
Luciano Retana
$6,850.00 across 1 reported transactions
- 5
Kyle Stanley
$2,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
MIS Implants Technologies, Inc. ranks #1291 of 1,925 by total payments (bottom 33% by spend) but is notably more concentrated than that alone would suggest -- #633 of 1,838 by HHI (top 34% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Aprecia Pharmaceuticals, LLC : $72.49 total payments, HHI 2625
- Carl Zeiss Meditec Cataract Technology Inc. : $122.7K total payments, HHI 2624
- Y-mAbs Therapeutics, Inc. : $208.8K total payments, HHI 2623
- Kalitec Direct LLC : $38.1K total payments, HHI 2618
- Fennec Pharmaceuticals, Inc. : $215.0K total payments, HHI 2615
- Tulsa Dental Products LLC : $2.7M total payments, HHI 2613
- MIS Implants Technologies, Inc. (this company) : $56.4K total payments, HHI 2592
- Atrium Medical Corporation : $13.1K total payments, HHI 2591
- DeGen Medical, Inc. : $324.9K total payments, HHI 2579
- Nutech Spine, Inc. : $22.0K total payments, HHI 2564
- Next Science LLC : $546.4K total payments, HHI 2560
- FEMSelect Inc. : $65.2K total payments, HHI 2552
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as MIS Implants Technologies, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about MIS Implants Technologies, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with MIS Implants Technologies, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Medela LLC
Cardinal Health Inc
Zambon USA Ltd.
Tonix Medicines, Inc.
Carbofix Spine Inc
Put this to use
MIS Implants Technologies, Inc. ranks #1291 of 1,925 by all-tracks total payments, led by "Compensation for Faculty or Speaker (Medical Education)".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Faculty or Speaker (Medical Education)" spend across every manufacturer, not just MIS Implants Technologies, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.